{"transactions":[{"id":1080836,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-28T21:08:48.000Z","date":"2025-07-24","kind":"other","planned":false,"acquired":false,"shares":287756,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"RAB Ventures (DFP) LLC (\"RAB Ventures\") distributed 287,756 shares to one of its members, Boro Partners Fund 1 (\"Boro\") in accordance with Boro's beneficial interest in RAB Ventures. The reporting person is a 10% beneficial owner of Boro, but disclaims investment control over Boro. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The distributed shares were owned by RAB Ventures, an entity controlled by the reporting person."}],"balance_after":2635881,"source":{"system":"sec-edgar","filing":"0000935836-25-000475","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000093583625000475/ownership.xml","form_type":"4"}},{"id":1103096,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Warrant","published_at":"2025-06-24T19:17:42.000Z","date":"2025-06-17","kind":"other","planned":false,"acquired":false,"shares":679224,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The exercise of the Common Warrant by RAB Ventures (DFP) LLC is exempt pursuant to Rule 16b-6."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Securities are owned by RAB Ventures (DFP) LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":1.198,"exercise_date":"2025-03-26","expiration_date":"2030-03-26","underlying":"Common Stock","underlying_shares":679224},"source":{"system":"sec-edgar","filing":"0000935836-25-000435","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000093583625000435/ownership.xml","form_type":"4"}},{"id":1103095,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T19:17:42.000Z","date":"2025-06-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":311128,"price":2.6154,"value":813724.1712,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the net exercise of a Common Stock Purchase Warrant (\"Common Warrant\") to purchase shares of common stock. The Common Warrant refers to such net exercise transaction as a \"Cashless Exercise.\" In connection with the Cashless Exercise, the Issuer and RAB Ventures (DFP) LLC entered into a Waiver Agreement, pursuant to which the Issuer agreed to waive the Common Warrant provision restricting Cashless Exercises to circumstances where the resale of the underlying shares of common stock is not covered by an effective registration statement under the Securities Act of 1933, as amended."},{"field":"shares","element":"transactionShares","label":"F3","text":"RAB Ventures (DFP) LLC received 368,096 shares of common stock on a net exercise of the Common Warrant to purchase 679,224 shares of common stock. The Issuer withheld 311,128 shares of common stock underlying the Common Warrant for payment of the exercise price, using the fair market value of the common stock on the date of exercise, June 17, 2025, of $2.6154. The fair market value of the common stock was determined based on the average of the volume weighted average price on each of the five (5) consecutive trading days ending immediately prior to the date of exercise, pursuant to the terms of the Common Warrant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Securities are owned by RAB Ventures (DFP) LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."}],"balance_after":2923637,"source":{"system":"sec-edgar","filing":"0000935836-25-000435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000093583625000435/ownership.xml","form_type":"4"}},{"id":1103094,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T19:17:42.000Z","date":"2025-06-17","kind":"other","planned":false,"acquired":true,"shares":679224,"price":1.198,"value":813710.352,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The exercise of the Common Warrant by RAB Ventures (DFP) LLC is exempt pursuant to Rule 16b-6."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Securities are owned by RAB Ventures (DFP) LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."}],"balance_after":3234765,"source":{"system":"sec-edgar","filing":"0000935836-25-000435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000093583625000435/ownership.xml","form_type":"4"}},{"id":1105390,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Equivalent Preferred Stock","published_at":"2025-06-20T20:59:24.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":false,"shares":6204,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class A Common Equivalent Preferred Stock, par value $0.0001 (the \"Preferred Stock\") into shares of the Issuer's common stock, par value $0.0001 (the \"Common Stock\") in accordance with and pursuant to the Certificate of Designation of Preferences, Rights and Limitations of Series A Common Stock Equivalent Convertible Preferred Stock (the \"Certificate of Designation\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities are owned by Helen Barasch Family Trust #1, an affiliate of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":620400},"source":{"system":"sec-edgar","filing":"0001079973-25-001047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000107997325001047/ownership.xml","form_type":"4"}},{"id":1105389,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Equivalent Preferred Stock","published_at":"2025-06-20T20:59:24.000Z","date":"2025-06-17","kind":"exercise","planned":false,"acquired":false,"shares":1595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class A Common Equivalent Preferred Stock, par value $0.0001 (the \"Preferred Stock\") into shares of the Issuer's common stock, par value $0.0001 (the \"Common Stock\") in accordance with and pursuant to the Certificate of Designation of Preferences, Rights and Limitations of Series A Common Stock Equivalent Convertible Preferred Stock (the \"Certificate of Designation\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":159500},"source":{"system":"sec-edgar","filing":"0001079973-25-001047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000107997325001047/ownership.xml","form_type":"4"}},{"id":1105388,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T20:59:24.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":true,"shares":620400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class A Common Equivalent Preferred Stock, par value $0.0001 (the \"Preferred Stock\") into shares of the Issuer's common stock, par value $0.0001 (the \"Common Stock\") in accordance with and pursuant to the Certificate of Designation of Preferences, Rights and Limitations of Series A Common Stock Equivalent Convertible Preferred Stock (the \"Certificate of Designation\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities are owned by Helen Barasch Family Trust #1, an affiliate of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."}],"balance_after":2555541,"source":{"system":"sec-edgar","filing":"0001079973-25-001047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000107997325001047/ownership.xml","form_type":"4"}},{"id":1105387,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T20:59:24.000Z","date":"2025-06-17","kind":"exercise","planned":false,"acquired":true,"shares":159500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class A Common Equivalent Preferred Stock, par value $0.0001 (the \"Preferred Stock\") into shares of the Issuer's common stock, par value $0.0001 (the \"Common Stock\") in accordance with and pursuant to the Certificate of Designation of Preferences, Rights and Limitations of Series A Common Stock Equivalent Convertible Preferred Stock (the \"Certificate of Designation\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion."}],"balance_after":1935141,"source":{"system":"sec-edgar","filing":"0001079973-25-001047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000107997325001047/ownership.xml","form_type":"4"}},{"id":1189049,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Warrant","published_at":"2025-03-28T17:25:59.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":679224,"price":0.125,"value":84903.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The holder may not exercise any portion of a Common Warrant to the extent that the holder would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities were purchased by RAB Ventures (DFP) LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein."}],"balance_after":679224,"derivative":{"exercise_price":1.198,"exercise_date":"2025-03-26","expiration_date":"2030-03-26","underlying":"Common Stock","underlying_shares":679224},"source":{"system":"sec-edgar","filing":"0001079973-25-000513","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000107997325000513/ownership.xml","form_type":"4"}},{"id":1189048,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-28T17:25:59.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":1358448,"price":1.0417,"value":1415095.2816,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities were purchased by RAB Ventures (DFP) LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein."}],"balance_after":1775641,"source":{"system":"sec-edgar","filing":"0001079973-25-000513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000107997325000513/ownership.xml","form_type":"4"}},{"id":1353133,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-11-25T16:38:26.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date."}],"balance_after":417193,"source":{"system":"sec-edgar","filing":"0001799191-24-000061","document":"wk-form4_1732570700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000179919124000061/wk-form4_1732570700.xml","form_type":"4"}},{"id":1471145,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T21:18:18.000Z","date":"2024-06-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":3559,"price":9.89,"value":35198.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person surrendered 3,559 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock grant."}],"balance_after":438355,"source":{"system":"sec-edgar","filing":"0001104659-24-074465","document":"tm2418148-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465924074465/tm2418148-1_4seq1.xml","form_type":"4"}},{"id":1522364,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2024-05-09T18:21:02.000Z","date":"2024-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":8547,"price":9.85,"value":84187.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person surrendered 8,547 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock grant."}],"balance_after":441914,"source":{"system":"sec-edgar","filing":"0001104659-24-059489","document":"tm2413346-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465924059489/tm2413346-2_4seq1.xml","form_type":"4"}},{"id":1530942,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2024-05-02T16:41:11.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, 100% of which will vest immediately on May 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This figure reflects a gift previously made by the reporting person, as disclosed in a Form 5 filed on April 8, 2024."}],"balance_after":450461,"source":{"system":"sec-edgar","filing":"0001104659-24-056426","document":"tm2413346-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465924056426/tm2413346-1_4seq1.xml","form_type":"4"}},{"id":1546095,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2024-04-08T16:28:38.000Z","date":"2022-11-18","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift/charitable donation of securities totaling 10,000 shares of the issuer's Common Stock to National Philanthropic Trust, a Pennsylvania non-profit corporation, to be held in a donor-advised fund."}],"balance_after":343907,"source":{"system":"sec-edgar","filing":"0001104659-24-044758","document":"tm2411299-1_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465924044758/tm2411299-1_5seq1.xml","form_type":"5"}},{"id":1604291,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2024-03-04T19:14:36.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":21206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted stock units, 100% of which will vest immediately on April 30, 2024."}],"balance_after":451632,"source":{"system":"sec-edgar","filing":"0001104659-24-030617","document":"tm247884-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465924030617/tm247884-1_4seq1.xml","form_type":"4"}},{"id":1604290,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2024-03-04T19:14:36.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":8984,"price":10.23,"value":91906.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person surrendered 8,984 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock grant."}],"balance_after":430426,"source":{"system":"sec-edgar","filing":"0001104659-24-030617","document":"tm247884-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465924030617/tm247884-1_4seq1.xml","form_type":"4"}},{"id":1693968,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2024-01-03T16:29:15.000Z","date":"2024-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":9226,"price":7.26,"value":66980.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reporting person surrendered 9,226 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock grant."}],"balance_after":439410,"source":{"system":"sec-edgar","filing":"0001104659-24-000857","document":"tm241613-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465924000857/tm241613-1_4seq1.xml","form_type":"4"}},{"id":1693967,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2024-01-03T16:29:15.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":22291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, 100% of which will vest immediately on February 29, 2024."}],"balance_after":448636,"source":{"system":"sec-edgar","filing":"0001104659-24-000857","document":"tm241613-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465924000857/tm241613-1_4seq1.xml","form_type":"4"}},{"id":1698935,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-12-28T17:58:50.000Z","date":"2023-12-26","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date."}],"balance_after":337193,"source":{"system":"sec-edgar","filing":"0001628280-23-042830","document":"wk-form4_1703804321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828023042830/wk-form4_1703804321.xml","form_type":"4"}},{"id":1751601,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2023-11-02T17:37:29.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":22891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, 100% of which will vest immediately on December 31, 2023."}],"balance_after":426345,"source":{"system":"sec-edgar","filing":"0001104659-23-113878","document":"tm2329711-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465923113878/tm2329711-1_4seq1.xml","form_type":"4"}},{"id":1789789,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2023-09-05T20:05:40.000Z","date":"2023-08-31","kind":"grant","planned":false,"acquired":true,"shares":13698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted stock units, 100% of which will vest immediately on October 31, 2023."}],"balance_after":403454,"source":{"system":"sec-edgar","filing":"0001104659-23-098420","document":"tm2325500-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465923098420/tm2325500-1_4seq1.xml","form_type":"4"}},{"id":1789788,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2023-09-05T20:05:40.000Z","date":"2023-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":6908,"price":11.93,"value":82412.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person surrendered 6,908 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock grant."}],"balance_after":389756,"source":{"system":"sec-edgar","filing":"0001104659-23-098420","document":"tm2325500-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465923098420/tm2325500-1_4seq1.xml","form_type":"4"}},{"id":1808999,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2023-08-14T19:01:51.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":17143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock, 100% of which will vest immediately on August 31, 2023."}],"balance_after":396664,"source":{"system":"sec-edgar","filing":"0001104659-23-091574","document":"tm2323660-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465923091574/tm2323660-3_4seq1.xml","form_type":"4"}},{"id":1844540,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-26T21:06:45.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":25614,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":379521,"source":{"system":"sec-edgar","filing":"0001104659-23-074905","document":"tm2319712-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465923074905/tm2319712-8_4seq1.xml","form_type":"4"}},{"id":1943561,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-03-21T21:01:19.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.55,"value":5500.0,"ownership":{"direct":true},"balance_after":257193,"source":{"system":"sec-edgar","filing":"0001628280-23-008836","document":"wf-form4_167944686729240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828023008836/wf-form4_167944686729240.xml","form_type":"4"}},{"id":1943560,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-03-21T21:01:19.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.55,"value":5500.0,"ownership":{"direct":true},"balance_after":247193,"source":{"system":"sec-edgar","filing":"0001628280-23-008836","document":"wf-form4_167944686729240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828023008836/wf-form4_167944686729240.xml","form_type":"4"}},{"id":1943559,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-03-21T21:01:19.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":2146,"price":0.548,"value":1176.008,"ownership":{"direct":true},"balance_after":237193,"source":{"system":"sec-edgar","filing":"0001628280-23-008836","document":"wf-form4_167944686729240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828023008836/wf-form4_167944686729240.xml","form_type":"4"}},{"id":1943558,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-03-21T21:01:19.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":7654,"price":0.55,"value":4209.7,"ownership":{"direct":true},"balance_after":235047,"source":{"system":"sec-edgar","filing":"0001628280-23-008836","document":"wf-form4_167944686729240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828023008836/wf-form4_167944686729240.xml","form_type":"4"}},{"id":1943557,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-03-21T21:01:19.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":9948,"price":0.55,"value":5471.4,"ownership":{"direct":true},"balance_after":227393,"source":{"system":"sec-edgar","filing":"0001628280-23-008836","document":"wf-form4_167944686729240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828023008836/wf-form4_167944686729240.xml","form_type":"4"}},{"id":1943556,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-03-21T21:01:19.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":0.548,"value":109.6,"ownership":{"direct":true},"balance_after":217445,"source":{"system":"sec-edgar","filing":"0001628280-23-008836","document":"wf-form4_167944686729240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828023008836/wf-form4_167944686729240.xml","form_type":"4"}},{"id":1943555,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-03-21T21:01:19.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":52,"price":0.549,"value":28.548,"ownership":{"direct":true},"balance_after":217245,"source":{"system":"sec-edgar","filing":"0001628280-23-008836","document":"wf-form4_167944686729240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828023008836/wf-form4_167944686729240.xml","form_type":"4"}},{"id":1943554,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-03-21T21:01:19.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.55,"value":5500.0,"ownership":{"direct":true},"balance_after":217193,"source":{"system":"sec-edgar","filing":"0001628280-23-008836","document":"wf-form4_167944686729240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828023008836/wf-form4_167944686729240.xml","form_type":"4"}},{"id":2074521,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-30T16:38:37.000Z","date":"2022-11-17","kind":"grant","acquired":true,"shares":65174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is filed to correct the number of restricted stock units granted due to an administrative error in applying the grant amount calculations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date."}],"balance_after":207193,"source":{"system":"sec-edgar","filing":"0001799191-22-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000179919122000060/edgardoc.xml","form_type":"4/A","original_submission_date":"2022-11-21"}},{"id":2109034,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-21T17:31:24.000Z","date":"2022-11-17","kind":"grant","acquired":true,"shares":22708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date."}],"balance_after":164727,"source":{"system":"sec-edgar","filing":"0001799191-22-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000179919122000031/edgardoc.xml","form_type":"4"}},{"id":2140743,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Earnout rights (Private placement warrants)","published_at":"2022-10-07T16:48:06.000Z","date":"2022-10-05","kind":"other","acquired":true,"shares":73024,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Represents Private Placement Warrants held in escrow, (i) 50% of which shall be released from escrow in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all warrants shall be released from escrow in the event of a qualifying change of control."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Represents Private Placement Warrants held in escrow, (i) 50% of which shall be released from escrow in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all warrants shall be released from escrow in the event of a qualifying change of control."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each whole private placement warrant (the \"Private Placement Warrant\") entitles the holder thereof to purchase one share of the issuer's common stock at an exercise price of $11.50 per share. The warrants are currently exercisable and will expire on November 12, 2026 or earlier upon redemption or liquidation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents Private Placement Warrants held in escrow, (i) 50% of which shall be released from escrow in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all warrants shall be released from escrow in the event of a qualifying change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each whole private placement warrant (the \"Private Placement Warrant\") entitles the holder thereof to purchase one share of the issuer's common stock at an exercise price of $11.50 per share. The warrants are currently exercisable and will expire on November 12, 2026 or earlier upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Represents Private Placement Warrants held in escrow, (i) 50% of which shall be released from escrow in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all warrants shall be released from escrow in the event of a qualifying change of control."}],"balance_after":73024,"derivative":{"exercise_price":11.5,"underlying":"Common stock","underlying_shares":73024},"source":{"system":"sec-edgar","filing":"0001628280-22-026163","document":"wf-form4_166517567146567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828022026163/wf-form4_166517567146567.xml","form_type":"4"}},{"id":2140742,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Private Placement Warrants","published_at":"2022-10-07T16:48:06.000Z","date":"2022-10-05","kind":"other","acquired":true,"shares":548503,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Each whole private placement warrant (the \"Private Placement Warrant\") entitles the holder thereof to purchase one share of the issuer's common stock at an exercise price of $11.50 per share. The warrants are currently exercisable and will expire on November 12, 2026 or earlier upon redemption or liquidation."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each whole private placement warrant (the \"Private Placement Warrant\") entitles the holder thereof to purchase one share of the issuer's common stock at an exercise price of $11.50 per share. The warrants are currently exercisable and will expire on November 12, 2026 or earlier upon redemption or liquidation."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each whole private placement warrant (the \"Private Placement Warrant\") entitles the holder thereof to purchase one share of the issuer's common stock at an exercise price of $11.50 per share. The warrants are currently exercisable and will expire on November 12, 2026 or earlier upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each whole private placement warrant (the \"Private Placement Warrant\") entitles the holder thereof to purchase one share of the issuer's common stock at an exercise price of $11.50 per share. The warrants are currently exercisable and will expire on November 12, 2026 or earlier upon redemption or liquidation."}],"balance_after":548503,"derivative":{"exercise_price":11.5,"underlying":"Common stock","underlying_shares":548503},"source":{"system":"sec-edgar","filing":"0001628280-22-026163","document":"wf-form4_166517567146567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828022026163/wf-form4_166517567146567.xml","form_type":"4"}},{"id":2140741,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Earnout rights (Series A Common Stock Equiv Conv Preferred)","published_at":"2022-10-07T16:48:06.000Z","date":"2022-10-05","kind":"other","acquired":true,"shares":894,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents shares of Common Equivalent Preferred Stock held in escrow, (i) 50% of which shall be released from escrow  in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all shares shall be released from escrow in the event of a qualifying change of control."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents shares of Common Equivalent Preferred Stock held in escrow, (i) 50% of which shall be released from escrow  in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all shares shall be released from escrow in the event of a qualifying change of control."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents shares of Common Equivalent Preferred Stock held in escrow, (i) 50% of which shall be released from escrow  in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all shares shall be released from escrow in the event of a qualifying change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents shares of Common Equivalent Preferred Stock held in escrow, (i) 50% of which shall be released from escrow  in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all shares shall be released from escrow in the event of a qualifying change of control."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities held by the Helen Barasch Family Trust #1 (the \"Trust\"), of which the reporting person is the investment manager and has voting and dispositive power over the securities held by the Trust, but disclaims beneficial ownership of these shares except to any pecuniary interest therein."}],"balance_after":894,"derivative":{"underlying":"Common stock","underlying_shares":89400},"source":{"system":"sec-edgar","filing":"0001628280-22-026163","document":"wf-form4_166517567146567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828022026163/wf-form4_166517567146567.xml","form_type":"4"}},{"id":2140740,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Stock Equivalent Convertible Preferred Stock","published_at":"2022-10-07T16:48:06.000Z","date":"2022-10-05","kind":"other","acquired":true,"shares":6204,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of common stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of common stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of common stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of common stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities held by the Helen Barasch Family Trust #1 (the \"Trust\"), of which the reporting person is the investment manager and has voting and dispositive power over the securities held by the Trust, but disclaims beneficial ownership of these shares except to any pecuniary interest therein."}],"balance_after":6204,"derivative":{"underlying":"Common stock","underlying_shares":620400},"source":{"system":"sec-edgar","filing":"0001628280-22-026163","document":"wf-form4_166517567146567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828022026163/wf-form4_166517567146567.xml","form_type":"4"}},{"id":2140739,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Earnout rights (Series A Common Stock Equiv Conv Preferred)","published_at":"2022-10-07T16:48:06.000Z","date":"2022-10-05","kind":"other","acquired":true,"shares":230,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents shares of Common Equivalent Preferred Stock held in escrow, (i) 50% of which shall be released from escrow  in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all shares shall be released from escrow in the event of a qualifying change of control."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents shares of Common Equivalent Preferred Stock held in escrow, (i) 50% of which shall be released from escrow  in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all shares shall be released from escrow in the event of a qualifying change of control."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents shares of Common Equivalent Preferred Stock held in escrow, (i) 50% of which shall be released from escrow  in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all shares shall be released from escrow in the event of a qualifying change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents shares of Common Equivalent Preferred Stock held in escrow, (i) 50% of which shall be released from escrow  in the event the issuer's stock price equals or exceeds $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period ending on November 12, 2023, and (ii) the remainder of which shall be released from escrow in the event the issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period ending November 12, 2024. Notwithstanding the forgoing, all shares shall be released from escrow in the event of a qualifying change of control."}],"balance_after":230,"derivative":{"underlying":"Common stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001628280-22-026163","document":"wf-form4_166517567146567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828022026163/wf-form4_166517567146567.xml","form_type":"4"}},{"id":2140738,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Stock Equivalent Convertible Preferred Stock","published_at":"2022-10-07T16:48:06.000Z","date":"2022-10-05","kind":"other","acquired":true,"shares":1595,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of common stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of common stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of common stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of common stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."}],"balance_after":1595,"derivative":{"underlying":"Common stock","underlying_shares":159500},"source":{"system":"sec-edgar","filing":"0001628280-22-026163","document":"wf-form4_166517567146567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828022026163/wf-form4_166517567146567.xml","form_type":"4"}},{"id":2140737,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-10-07T16:48:06.000Z","date":"2022-10-05","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities held by the Helen Barasch Family Trust #1 (the \"Trust\"), of which the reporting person is the investment manager and has voting and dispositive power over the securities held by the Trust, but disclaims beneficial ownership of these shares except to any pecuniary interest therein."}],"balance_after":8,"source":{"system":"sec-edgar","filing":"0001628280-22-026163","document":"wf-form4_166517567146567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828022026163/wf-form4_166517567146567.xml","form_type":"4"}},{"id":2140736,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-10-07T16:48:06.000Z","date":"2022-10-05","kind":"other","acquired":true,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents securities received in distributions to LLC members, on a pro rata basis for no consideration, in exempt transactions under Rule 16a-9."}],"balance_after":142019,"source":{"system":"sec-edgar","filing":"0001628280-22-026163","document":"wf-form4_166517567146567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828022026163/wf-form4_166517567146567.xml","form_type":"4"}},{"id":2222313,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T16:26:54.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":14970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":353907,"source":{"system":"sec-edgar","filing":"0001104659-22-074326","document":"tm2219351-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465922074326/tm2219351-3_4seq1.xml","form_type":"4"}},{"id":2320381,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-03-23T19:34:35.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":45905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on November 12, 2022, subject to continued service with the Company through such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units that vest in full on November 12, 2022, subject to continued service with the Company through such vesting date."}],"balance_after":142018,"source":{"system":"sec-edgar","filing":"0001628280-22-007094","document":"wf-form4_164807845002324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000162828022007094/wf-form4_164807845002324.xml","form_type":"4"}},{"id":2496315,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T18:01:02.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":1200,"price":7.2022,"value":8642.64,"ownership":{"direct":true},"balance_after":96113,"source":{"system":"sec-edgar","filing":"0001104659-21-143688","document":"tm2133957-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921143688/tm2133957-1_4seq1.xml","form_type":"4"}},{"id":2496314,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T18:01:02.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":1800,"price":6.858,"value":12344.4,"ownership":{"direct":true},"balance_after":94913,"source":{"system":"sec-edgar","filing":"0001104659-21-143688","document":"tm2133957-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921143688/tm2133957-1_4seq1.xml","form_type":"4"}},{"id":2496313,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T18:01:02.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":2000,"price":6.8088,"value":13617.6,"ownership":{"direct":true},"balance_after":93113,"source":{"system":"sec-edgar","filing":"0001104659-21-143688","document":"tm2133957-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921143688/tm2133957-1_4seq1.xml","form_type":"4"}},{"id":2496312,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T06:01:24.000Z","date":"2021-11-23","kind":"purchase","acquired":true,"shares":4500,"price":6.348,"value":28566.0,"ownership":{"direct":true},"balance_after":91113,"source":{"system":"sec-edgar","filing":"0001104659-21-143245","document":"tm2133425d7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921143245/tm2133425d7_4seq1.xml","form_type":"4"}},{"id":2496311,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T06:01:24.000Z","date":"2021-11-23","kind":"purchase","acquired":true,"shares":500,"price":6.2667,"value":3133.35,"ownership":{"direct":true},"balance_after":86613,"source":{"system":"sec-edgar","filing":"0001104659-21-143245","document":"tm2133425d7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921143245/tm2133425d7_4seq1.xml","form_type":"4"}},{"id":2505314,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T20:43:01.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":1000,"price":10.115,"value":10115.0,"ownership":{"direct":true},"balance_after":86113,"source":{"system":"sec-edgar","filing":"0001104659-21-141467","document":"tm2133425-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921141467/tm2133425-5_4seq1.xml","form_type":"4"}},{"id":2505313,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2021-11-18T20:22:54.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-141455","document":"tm2133425-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921141455/tm2133425-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-11-16"}},{"id":2505312,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T20:22:54.000Z","date":"2021-11-12","kind":"disposition_to_issuer","acquired":false,"shares":14887,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 12, 2021, in connection with the Business Combination, Mr. Barasch, forfeited 14,887 of his shares of the Issuer's common stock to the Issuer pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, by and among, DFP And TOI and certain DFP directors and officers, including Mr. Barasch."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"On November 12, 2021, in connection with the Business Combination, Mr. Barasch, forfeited 14,887 of his shares of the Issuer's common stock to the Issuer pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, by and among, DFP And TOI and certain DFP directors and officers, including Mr. Barasch."}],"balance_after":85113,"source":{"system":"sec-edgar","filing":"0001104659-21-141455","document":"tm2133425-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921141455/tm2133425-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-11-16"}},{"id":2505311,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T20:22:54.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acquisitions Corp. (\"DFP\"), Orion Merger Sub I, Inc. (\"First Merger Sub\"), Orion Merger Sub II, LLC (\"Second Merger Sub\"), and TOI Parent, Inc. (\"Old TOI\"), First Merger Sub merged into Old TOI, with Old TOI being the surviving corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the \"Business Combination\"). In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acquisitions Corp. (\"DFP\"), Orion Merger Sub I, Inc. (\"First Merger Sub\"), Orion Merger Sub II, LLC (\"Second Merger Sub\"), and TOI Parent, Inc. (\"Old TOI\"), First Merger Sub merged into Old TOI, with Old TOI being the surviving corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the \"Business Combination\"). In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001104659-21-141455","document":"tm2133425-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921141455/tm2133425-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-11-16"}},{"id":2511372,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2021-11-16T21:59:23.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-140230","document":"tm2132979-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921140230/tm2132979-16_4seq1.xml","form_type":"4"}},{"id":2511371,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-16T21:59:23.000Z","date":"2021-11-12","kind":"disposition_to_issuer","acquired":false,"shares":14887,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acqusitions Corp. (\"DFP\"), Orion Merger Sub I, Inc. (\"First Merger Sub\"), Orion Merger Sub II, LLC (\"Second Merger Sub\"), and TOI Parent, Inc. (\"Old TOI\"), First Merger Sub merged into Old TOI, with Old TOI being the surivivng corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the \"Business Combination\"). In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7."}],"balance_after":85113,"source":{"system":"sec-edgar","filing":"0001104659-21-140230","document":"tm2132979-16_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921140230/tm2132979-16_4seq1.xml","form_type":"4"}},{"id":2511370,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-16T21:59:23.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acqusitions Corp. (\"DFP\"), Orion Merger Sub I, Inc. (\"First Merger Sub\"), Orion Merger Sub II, LLC (\"Second Merger Sub\"), and TOI Parent, Inc. (\"Old TOI\"), First Merger Sub merged into Old TOI, with Old TOI being the surivivng corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the \"Business Combination\"). In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acqusitions Corp. (\"DFP\"), Orion Merger Sub I, Inc. (\"First Merger Sub\"), Orion Merger Sub II, LLC (\"Second Merger Sub\"), and TOI Parent, Inc. (\"Old TOI\"), First Merger Sub merged into Old TOI, with Old TOI being the surivivng corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the \"Business Combination\"). In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001104659-21-140230","document":"tm2132979-16_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921140230/tm2132979-16_4seq1.xml","form_type":"4"}},{"id":2591359,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T16:30:03.000Z","date":"2021-08-23","kind":"grant","acquired":true,"shares":9017,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":338937,"source":{"system":"sec-edgar","filing":"0001104659-21-109351","document":"tm2124383-11_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921109351/tm2124383-11_4.xml","form_type":"4"}},{"id":2674401,"issuer":{"id":87127,"kind":"organization","name":"CareMax, Inc.","symbol":"CMAX"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2021-06-10T21:41:53.000Z","date":"2021-06-08","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 8, 2021, Deerfield Healthcare Technology Acquisitions Corp. consummated its business combination (the \"Business Combination\") with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC, with the combined company being renamed \"CareMax, Inc.\" In connection with the consummation of the Business Combination, the shares of Class B common stock automatically converted into shares of Class A common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2021, Deerfield Healthcare Technology Acquisitions Corp. consummated its business combination (the \"Business Combination\") with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC, with the combined company being renamed \"CareMax, Inc.\" In connection with the consummation of the Business Combination, the shares of Class B common stock automatically converted into shares of Class A common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 8, 2021, Deerfield Healthcare Technology Acquisitions Corp. consummated its business combination (the \"Business Combination\") with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC, with the combined company being renamed \"CareMax, Inc.\" In connection with the consummation of the Business Combination, the shares of Class B common stock automatically converted into shares of Class A common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-21-079698","document":"tm2119285-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921079698/tm2119285-1_4seq1.xml","form_type":"4"}},{"id":2674400,"issuer":{"id":87127,"kind":"organization","name":"CareMax, Inc.","symbol":"CMAX"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-10T21:41:53.000Z","date":"2021-06-08","kind":"exercise","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 8, 2021, Deerfield Healthcare Technology Acquisitions Corp. consummated its business combination (the \"Business Combination\") with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC, with the combined company being renamed \"CareMax, Inc.\" In connection with the consummation of the Business Combination, the shares of Class B common stock automatically converted into shares of Class A common stock on a one-for-one basis."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001104659-21-079698","document":"tm2119285-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921079698/tm2119285-1_4seq1.xml","form_type":"4"}},{"id":2867284,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-02-11T19:43:17.000Z","date":"2020-12-21","kind":"gift","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":329920,"source":{"system":"sec-edgar","filing":"0001104659-21-020935","document":"tm214849-17_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465921020935/tm214849-17_5seq1.xml","form_type":"5"}},{"id":3033486,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-09-11T21:02:07.000Z","date":"2020-09-09","kind":"grant","acquired":true,"shares":9017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 5,000 shares previously granted to the reporting person that were inadvertently omitted from the reporting person's Form 4 filed on December 18, 2019."}],"balance_after":344920,"source":{"system":"sec-edgar","filing":"0001104659-20-104528","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465920104528/a4.xml","form_type":"4"}},{"id":3337324,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-12-18T21:31:13.000Z","date":"2019-12-16","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001104659-19-073987","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465919073987/a4.xml","form_type":"4"}},{"id":3373277,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Private Placement Warrant","published_at":"2019-11-13T21:39:27.000Z","date":"2019-11-08","kind":"other","acquired":false,"shares":1690000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the \"Sponsor\"), DFB Healthcare Acquisitions Corp. (\"DFB\") and AdaptHealth Holdings, LLC (\"AdaptHealth\"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the \"Sponsor\"), DFB Healthcare Acquisitions Corp. (\"DFB\") and AdaptHealth Holdings, LLC (\"AdaptHealth\"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein."}],"balance_after":2643333,"derivative":{"exercise_price":11.5,"exercise_date":"2019-12-08","expiration_date":"2024-11-08","underlying":"Common Stock","underlying_shares":1690000},"source":{"system":"sec-edgar","filing":"0001104659-19-063570","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465919063570/a4.xml","form_type":"4"}},{"id":3373276,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T21:39:27.000Z","date":"2019-11-08","kind":"other","acquired":false,"shares":2373152,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the \"Sponsor\"), DFB Healthcare Acquisitions Corp. (\"DFB\") and AdaptHealth Holdings, LLC (\"AdaptHealth\"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the \"Sponsor\"), DFB Healthcare Acquisitions Corp. (\"DFB\") and AdaptHealth Holdings, LLC (\"AdaptHealth\"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein."}],"balance_after":3672500,"source":{"system":"sec-edgar","filing":"0001104659-19-063570","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465919063570/a4.xml","form_type":"4"}},{"id":3974119,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-04-03T16:57:31.000Z","date":"2018-04-02","kind":"other","acquired":false,"shares":921848,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein."}],"balance_after":6045652,"source":{"system":"sec-edgar","filing":"0001104659-18-022201","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465918022201/a4.xml","form_type":"4"}},{"id":4037748,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Private Placement Warrant","published_at":"2018-02-23T17:31:08.000Z","date":"2018-02-21","kind":"purchase","acquired":true,"shares":4333333,"price":1.5,"value":6499999.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrants will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination or February 21, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrants expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein."}],"balance_after":4333333,"derivative":{"exercise_price":11.5,"underlying":"Common Stock","underlying_shares":4333333},"source":{"system":"sec-edgar","filing":"0001104659-18-011752","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000110465918011752/a4.xml","form_type":"4"}},{"id":4338567,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":64696,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":6.09,"underlying":"Common Stock","underlying_shares":64696},"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338566,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":21565,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":6.09,"underlying":"Common Stock","underlying_shares":21565},"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338565,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":61568,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":8.41,"underlying":"Common Stock","underlying_shares":61568},"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338564,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":64696,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":6.09,"underlying":"Common Stock","underlying_shares":64696},"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338563,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":21565,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":6.09,"underlying":"Common Stock","underlying_shares":21565},"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338562,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":30784,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":8.41,"underlying":"Common Stock","underlying_shares":30784},"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338561,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":30784,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":8.41,"underlying":"Common Stock","underlying_shares":30784},"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338560,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":78200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":6.05,"underlying":"Common Stock","underlying_shares":78200},"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338559,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":234597,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":6.05,"underlying":"Common Stock","underlying_shares":234597},"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338558,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":6.18,"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338557,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":220768,"ownership":{"direct":false,"nature":"Barasch Family Trust #1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the \"Merger Agreement\"), by and among Universal American Corp. (the \"Company\"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the \"Effective Time\"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the \"Per Share Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338556,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":494400,"ownership":{"direct":false,"nature":"Barasch Family Trust #3"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the \"Merger Agreement\"), by and among Universal American Corp. (the \"Company\"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the \"Effective Time\"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the \"Per Share Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338555,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":33872,"ownership":{"direct":false,"nature":"HB Family Trust #1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the \"Merger Agreement\"), by and among Universal American Corp. (the \"Company\"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the \"Effective Time\"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the \"Per Share Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338554,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":215835,"ownership":{"direct":false,"nature":"Tara Acquisition LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the \"Merger Agreement\"), by and among Universal American Corp. (the \"Company\"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the \"Effective Time\"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the \"Per Share Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338553,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":30124,"ownership":{"direct":false,"nature":"By Daughter (Emily)"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the \"Merger Agreement\"), by and among Universal American Corp. (the \"Company\"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the \"Effective Time\"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the \"Per Share Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338552,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":23080,"ownership":{"direct":false,"nature":"By Daughter (Natalie)"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the \"Merger Agreement\"), by and among Universal American Corp. (the \"Company\"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the \"Effective Time\"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the \"Per Share Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338551,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":28180,"ownership":{"direct":false,"nature":"By Son (Benjamin)"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the \"Merger Agreement\"), by and among Universal American Corp. (the \"Company\"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the \"Effective Time\"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the \"Per Share Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338550,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":222077,"ownership":{"direct":false,"nature":"By Wife"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the \"Merger Agreement\"), by and among Universal American Corp. (the \"Company\"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the \"Effective Time\"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the \"Per Share Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338549,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":423468,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these unvested shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the Per Share Merger Consideration, subject to conditions set forth in the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4338548,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-02T19:01:36.000Z","date":"2017-04-28","kind":"disposition_to_issuer","acquired":false,"shares":1664791,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the \"Merger Agreement\"), by and among Universal American Corp. (the \"Company\"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the \"Effective Time\"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the \"Per Share Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-17-000935","document":"es1700587_4-barasch.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000095014217000935/es1700587_4-barasch.xml","form_type":"4"}},{"id":4398412,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-07T17:20:26.000Z","date":"2017-03-04","kind":"tax_withholding","acquired":false,"shares":11164,"price":9.96,"value":111193.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by issuer to satisfy statutory tax withholding on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents common stock including 423,468 shares of unvested restricted stock."}],"balance_after":2088259,"source":{"system":"sec-edgar","filing":"0001593968-17-000410","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000159396817000410/primary_01.xml","form_type":"4"}},{"id":4450335,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-14T17:55:36.000Z","date":"2017-02-13","kind":"tax_withholding","acquired":false,"shares":10055,"price":9.96,"value":100147.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by issuer to satisfy statutory tax withholding on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents common stock including 443,468 shares of unvested restricted stock."}],"balance_after":2099423,"source":{"system":"sec-edgar","filing":"0001593968-17-000289","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000159396817000289/primary_01.xml","form_type":"4"}},{"id":4464609,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-07T16:40:39.000Z","date":"2017-02-06","kind":"exercise","acquired":false,"shares":400000,"price":7.87,"value":3148000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.87,"expiration_date":"2017-02-09","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001593968-17-000221","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000159396817000221/primary_01.xml","form_type":"4"}},{"id":4464608,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-07T16:40:39.000Z","date":"2017-02-06","kind":"tax_withholding","acquired":false,"shares":20317,"price":9.96,"value":202357.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by issuer to satisfy statutory tax withholding on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Represents common stock including 461,481 shares of unvested restricted stock."}],"balance_after":2109478,"source":{"system":"sec-edgar","filing":"0001593968-17-000221","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000159396817000221/primary_01.xml","form_type":"4"}},{"id":4464607,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-07T16:40:39.000Z","date":"2017-02-06","kind":"tax_withholding","acquired":false,"shares":362872,"price":9.96,"value":3614205.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares surrendered to issuer in payment of exercise price and tax liability in connection with stock option exercise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Represents common stock including 461,481 shares of unvested restricted stock."}],"balance_after":2129795,"source":{"system":"sec-edgar","filing":"0001593968-17-000221","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000159396817000221/primary_01.xml","form_type":"4"}},{"id":4464606,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-07T16:40:39.000Z","date":"2017-02-06","kind":"exercise","acquired":true,"shares":400000,"price":7.87,"value":3148000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Represents common stock including 461,481 shares of unvested restricted stock."}],"balance_after":2492667,"source":{"system":"sec-edgar","filing":"0001593968-17-000221","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000159396817000221/primary_01.xml","form_type":"4"}},{"id":4464605,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-07T16:40:39.000Z","date":"2017-02-04","kind":"tax_withholding","acquired":false,"shares":12855,"price":9.98,"value":128292.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by issuer to satisfy statutory tax withholding on vesting of performance shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents common stock including 497,878 shares of unvested restricted stock."}],"balance_after":2092667,"source":{"system":"sec-edgar","filing":"0001593968-17-000221","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000159396817000221/primary_01.xml","form_type":"4"}},{"id":4464604,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-07T16:40:39.000Z","date":"2017-02-04","kind":"tax_withholding","acquired":false,"shares":12855,"price":9.98,"value":128292.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by issuer to satisfy statutory tax withholding on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents common stock including 520,907 shares of unvested restricted stock."}],"balance_after":2105522,"source":{"system":"sec-edgar","filing":"0001593968-17-000221","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000159396817000221/primary_01.xml","form_type":"4"}},{"id":4469265,"issuer":{"id":176574,"kind":"organization","name":"UNIVERSAL AMERICAN CORP.","symbol":"UAM"},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-03T17:08:39.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":140813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock which vests in four equal annual installments beginning February 2, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents common stock including 543,936 shares of unvested restricted stock."}],"balance_after":2118377,"source":{"system":"sec-edgar","filing":"0001593968-17-000197","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000159396817000197/primary_01.xml","form_type":"4"}}]}